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Background: Malaria is a serious disease that is causing huge toll on human health. The parasites 
causing this disease have developed resistance toward the current mainstream drugs. Tinospora 
crispa Miers is a well-known ethnopharmacological plant of Malaysia and has been traditionally 
used to treat malaria, fever, and other parasite-related illnesses. Objective: The present study 
investigated the potential of the crude methanol extract and antiparasitic fractions of T. crispa stem 
to exert antimalarial activity against Plasmodium berghei. Materials and Methods: The potent 
antiparasitic fractions of T. crispa, F4, and F5 were isolated in the previous study against 
Toxoplasma gondii. The same antiparasitic fractions along with crude methanol extract of different 
doses (10, 50, 100 mg/kg b. w.) were employed in the present study to determine the antimalarial 
activity against P. berghei ANKA strain. The survival curves of the treated mice were plotted by 
employing the log-rank (Mantel–Cox) test. The chemical composition of the most potent fraction 
F5 was determined spectrometrically using electrospray ionization-mass spectrometry (MS). 
Results: In a murine P. berghei model, fraction F5 displayed the highest parasitemia suppression 
effects compared to the crude methanol extract and other fraction. Subsequent chemical analysis 
by MS on fraction F5 has led to the tentative identification of 13-hydroperoxyoctadeca-9, 11-
dienoic acid (13[S]-HPODE) compound. Conclusion: The crude methanol extract of T. crispa and 
its fraction F5 possess potent antimalarial activities, and the tentative discovery of the 13(S)-
HPODE bioactive compound may serve as a precursor for developing a semisynthetic antiparasitic 
drug with enhanced efficacy and low toxicity. 
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